Applied DNA to Report First Quarter Fiscal 2025 Financial Results After Market Close on Thursday, February 13, 2025
Applied DNA Sciences (NASDAQ:APDN) has announced it will release its first quarter fiscal 2025 financial results after market close on Thursday, February 13, 2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Applied DNA Sciences (NASDAQ:APDN) has announced it will release its first quarter fiscal 2025 financial results after market close on Thursday, February 13, 2025. The company will host a conference call and webcast for shareholders and investors at 4:30 p.m. ET on the same day.
The conference call will be accessible via multiple channels including domestic toll-free, international, and Canadian toll-free numbers. A live webcast will be available, and an accompanying slide presentation will be embedded in both live and replay formats. A replay of the conference call will be available for 7 days following the event through various access numbers with the replay access code 7896562.
Details
News Market Reaction – APDN
The recorded move for APDN in the trading session of this news was +3.83%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Investor Call and Webcast Scheduled for 4:30 P.M ET
STONY BROOK, NY / ACCESS Newswire / February 12, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in polymerase chain reaction (PCR)-based technologies, today announced that it will release its first quarter fiscal 2025 financial results after the market close on Thursday, February 13, 2025.
The Company will host a conference call for shareholders and the investment community at 4:30 p.m. ET on that same day.
Webcast and Conference Call Date & Time: Thursday, February 13 @ 4:30 p.m. ET
Dial In:
Domestic callers (toll free): 844-887-9402
International callers: 412-317-6798
Canadian callers (toll free): 866-605-3852
Live webcast: https://event.choruscall.com/mediaframe/webcast.html?webcastid=3UkskFxG
A replay of the conference call will be available for 7 days following the conclusion of the call:
Replay for domestic callers (toll free): 877-344-7529, replay access code 7896562
Replay for international callers: 412-317-0088, replay access code 7896562
Replay for Canadian callers (toll free): 855-669-9658, replace access code 7896562
An accompanying slide presentation will be embedded in the webcast (live and replay) that can also be accessed via the ‘Company Presentations' page of the Applied DNA investor relations website (https://investors.adnas.com/corporate-profile/company-presentation/). The webcast replay of the call will be available approximately one hour after the end of the call on the ‘Company Events' page (https://investors.adnas.com/news-events/company-events/).
About Applied DNA Sciences
Applied DNA Sciences is a biotechnology company developing technologies to produce and detect deoxyribonucleic acid ("DNA"). Using the polymerase chain reaction ("PCR") to enable both the production and detection of DNA, we operate in three primary business markets: (i) the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and the development and sale of a proprietary RNA polymerase ("RNAP") for use in the production of mRNA therapeutics; and, (ii) the detection of DNA and RNA in molecular diagnostics and genetic testing services; and (iii) the manufacture and detection of DNA for industrial supply chain security services.
Visit adnas.com for more information. Follow us on X and LinkedIn. Join our mailing list.
For additional information:
Investor Relations: Sanjay M. Hurry, 917-733-5573, sanjay.hurry@adnas.com
Web: https://investors.adnas.com/
SOURCE: Applied DNA Sciences
View the original press release on ACCESS Newswire
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.